Mit Magzter GOLD unbegrenztes Potenzial nutzen

Mit Magzter GOLD unbegrenztes Potenzial nutzen

Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur

$149.99
 
$74.99/Jahr

Versuchen GOLD - Frei

Vietnam's VinFast Has a Plan to Disrupt India's EV Market

Mint Mumbai

|

September 08, 2025

VinFast is planning to price premium models competitively, localize car parts, and grow outlets to 27 cities

- Ayaan Kartik

Vietnam's VinFast Has a Plan to Disrupt India's EV Market

As competition in India's electric vehicles space intensifies, Vietnamese conglomerate Vingroup's flagship automaker VinFast has chalked out a three-pronged strategy to take on carmakers like Tata Motors, and Mahindra and Mahindra.

In a bid to win over customers and capture market share in India, VinFast aims to price premium models aggressively, source car parts locally, and grow dealerships to 27 cities.

VinFast has begun its India campaign with the launch of two new electric sports utility vehicles (SUVs), VF6 and VF7. While variants of the VF6 are priced at ₹16.49-18.29 lakh, the more advanced VF7 has prices in the range of ₹20.89 lakh to ₹25.49 lakh.

The price points place its models in direct competition with Indian carmakers Tata Motors, with the Tata Curvv EV and Tata Harrier EV, and M&M, offering the BE6 and XEV 9e in a similar price bracket.

JSW MG Motor, a joint venture between India's JSW and China's SAIC, offers its flagship Windsor EV and ZS EV in a similar price range, while Korean carmaker Hyundai Motor India Ltd markets the Creta Electric.

WEITERE GESCHICHTEN VON Mint Mumbai

Mint Mumbai

Mint Mumbai

Gen Alpha will make new rules for their workplace

Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’

time to read

3 mins

December 01, 2025

Mint Mumbai

EC extends electoral roll revision by a week to II Dec; final list on 14 Feb

The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.

time to read

2 mins

December 01, 2025

Mint Mumbai

THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS

These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.

time to read

3 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

Green hydrogen: Fast fashion could help bump up demand

A boom in its use for clean synthetic inputs might make a difference

time to read

3 mins

December 01, 2025

Mint Mumbai

Let's be a bit more selective in using the word 'reforms'

Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.

time to read

3 mins

December 01, 2025

Mint Mumbai

As mid-cap alpha shrinks, should you consider passive strategies?

Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey

time to read

4 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

With $2.2 bn fund, ChrysCap has appetite for riskier bets

MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing

time to read

3 mins

December 01, 2025

Mint Mumbai

GDP growth of 8% plus: How to sustain this pace

Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships

time to read

2 mins

December 01, 2025

Mint Mumbai

INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES

Detection tools today are not universal or consistent across languages

time to read

5 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

APIs to innovation: Bulk drug makers ramp up CDMO bets

Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.

time to read

2 mins

December 01, 2025

Listen

Translate

Share

-
+

Change font size